The results of meta-analysis indicated that higher PANDAR expression levels were significantly associated with advanced tumor stage (OR = 2.05, 95% CI 0.99–4.27, p = 0.045) (Figure 6F), deeper depth of invasion (OR = 3.95, 95% CI 2.35–6.63, p < 0.001) (Figure 6G), more lymph node metastasis (OR = 1.92, 95% CI 0.93–3.98, p = 0.049) (Figure 6E), and farther distant metastasis (OR = 2.87, 95% CI 1.60–5.16, p < 0.001) (Figure 6H). Here, PANDAR is linked to neoplasm.